Skip to main content

Role of intravoxel incoherent motion diffusion-weighted MRI in differentiation of renal cell carcinoma subtypes

Abstract

Background

Renal cell carcinoma is the most fatal form of renal tumors, representing about ninety percent of all renal cancers. There are different variations in prognosis among various histological types of RCC. In recent years, there has been a greater emphasis on differentiating between RCC subtypes. Evaluation of different subtypes of renal cell carcinoma using intravoxel incoherent motion (IVIM) diffusion-weighted MRI is the aim of this study.

Results

Clear cell renal cell carcinoma (CCRCCs) showed highest f and D values, followed by chromophobe renal cell carcinoma (ChRCCs), while papillary renal cell carcinoma (PRCCs) had the lowest values. CCRCCs had significantly different D and f values compared to non-clear types (PRCC and ChRCC) (P < 0.05). The D* values of CCRCC were the highest, PCRCC had intermediate values, while ChRCCs had the lowest values (P < 0.05). The D* values of ChRCCs demonstrated significant difference when compared to both CCRCCs and PRCCs (P < 0.05). The cutoff points of D, D* and f parameters for distinguishing CCRCCs from non-clear cell types (ChRCCs and PRCC) were 0.835, 0.0355 and 0.335, respectively, yielding specificities of 97.2%, 83.3% and 76.5% and sensitivities of 100%, 57.5% and 72.7%, respectively.

Conclusion

Intravoxel incoherent motion (IVIM) can be utilized to distinguish renal cell carcinoma subtypes.

Background

Renal cell carcinoma (RCC) is a multiple variety of tumors that originates from the epithelium of the renal tubules. It is considered as a group of illness with discrete histological types, molecular and genetic variations with distinct clinical prognosis [1].

Clear cell, papillary and chromophobe RCCs are the most predominant subtypes of RCC, constituting approximately 75%, 15% and 5% of RCCs cases, respectively. According to the 2004 WHO classification system [2], clear cell carcinomas type typically exhibits a less favorable prognosis with a five-year survival rate ranging from 44 to 69% [3].

Differentiation of renal masses is useful in distinguishing those that require active surveillance or ablation from those requiring surgery without the need for biopsy [4]. Histological classification of RCC is performed preoperative by invasive methods through percutaneous biopsy. Recently, a large number of studies have documented the value of imaging in the non-invasive evaluation of different RCC subtypes [5].

Non-invasive techniques, such as MRI, have been thoroughly detailed in the assessment of common frequent subtypes of RCC [6]. Both diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) measurements were extensively utilized in the characterization as well as identification of renal masses [7, 8]. However, the ADC is determined with a monoexponential model and does not adequately reflect the diffusion factor of tissues as it involves the impacts of perfusion (the capillaries microcirculation of blood) and diffusion (water molecules movement inside tissue) [9].

Intravoxel incoherent motion (IVIM) DWI, initially documented by Le Bihan et al., uses the biexponential model with several b values to calculate both tissues diffusion and perfusion, independently [9]. Main IVIM parameters include true diffusion coefficient (D), pseudo-diffusion (D*) and perfusion fraction (f) that represent the tissue true molecular diffusion, perfusion of blood capillary microcirculation and the microcapillary perfusion fraction, respectively [9, 10].

IVIM MRI is sensitive to both molecular diffusion in tissues and to microcirculation (perfusion) based on the assumption that the flow of blood through capillaries mimics a diffusion process, due to the pseudo-random organization of capillaries in tissue [11]. Microcirculation contributes greatly to the diffusion-weighted MRI signal together with genuine water molecule diffusion in tissues [12, 13].

A key advantage of IVIM MRI is ability to give quantitative data about microcirculation without using contrast agents, a significant benefit in terms of price, acquisition times and suitability for patients who are contraindicated to receive gadolinium-based contrast agents [14, 15].

Methods

  • This prospective study was done from May 2023 to December 2023. All cases were referred to our radiology department at urology and nephrology center from the clinic within the same center. Our study received permission by the institutional board of ethics, and each patient gave his informed consent after being fully informed about the benefits and hazards of the procedure. There were no other obvious hazards to the patients in this study.

  • Inclusion criteria Patients over the age of eighteen years who had solid renal mass parenchymal in origin that have been identified by CT or US.

  • Exclusion criteria Patients who are contraindicated for MRI study (like patient with metallic prostheses or pacemakers), cases who refused consent and cases with no histology results

MRI technique

MRI examination was performed for each patient using a 3 Tesla MRI scanner (Phillips, Ingenia 3 T, Best, The Netherlands). Phased-array body coil using M-Dixon program was utilized in our procedure, and imaging was done in the supine position including these sequences: (T2WI, fat-suppressed T1W sequences, DWI, IVIM). As regards the IVIM, in the axial or coronal planes, we applied single-shot echo-planar imaging sequence using a respiratory belt with eight b values (0, 200, 400, 600, 800, 1000, 1200 and 1400 s/mm2). Other parameters were: 24 slices covering both kidneys, (TE) = 33.2 × 86.6 ms, (TR) = 1000 ms, matrix = 96 × 128, FOV = 36 × 36 cm. The mean acquisition time of IVIM sequence was 16.6 + 3.2 min.

Image analysis

The DICOM pictures were sent to the vendor-supplied workstation (Intellispace portal Workspace 6.0.1 Philips Medical Systems Netherlands B.V). The procedure was done without knowledge of the pathology results. Using IVIM protocol, we got measurements for D, D* and f. ROIs of the lesion (100–225 mm2) were manually drawn trying to avoid aliasing artifacts appeared in an image, calcification inside the mass and cystic degeneration. We obtained three measurements for each parameter, and the average measurement was taken.

Statistical analysis and data interpretation

Version 25 of the SPSS program (SPSS Inc., PASW statistics for windows version 25. Chicago: SPSS Inc.) was used to analyze the data. Numbers and percentages were used to describe the qualitative data. After determining the normalcy of the quantitative data using the Kolmogrov–Smirnov or Shapiro–Wilk tests, the data were presented using the mean ± standard deviation for normally distributed data. The results were evaluated for significance at the (≤ 0.05) level.

When comparing more than two independent groups, the one-way ANOVA test was utilized and the post hoc Tukey test was applied to identify pair-wise comparisons. The best cutoff point was determined by calculating the validity (sensitivity & specificity) of continuous variables using the receiver operating characteristics curve (ROC curve). Using cross-tabulation, predictive values and accuracy are evaluated.

Pathological analysis

Final diagnosis by histopathology was obtained after excision of renal masses surgically by either partial or radical nephrectomy.

Results

Seventy-six patients with renal cell carcinomas confirmed by histology were included in our prospective study (35 females and 41 males). Their age range was (29–77) years with average age that was 53.13 years. We observed no significant differences for either age (p = 0.81) or sex (p = 0.34). The distribution of their pathology was 40 clear cell RCCs (52.6%), 22 papillary RCCs (28.9%) and 14 chromophobe RCCs (18.5%) (Fig. 1).

Fig. 1
figure 1

Histopathology of the studied cases

D values were highest for CCRCCs (1.44 ± 0.19 × 10−3mm2/s) followed by ChRCC (0.751 ± 0.054 × 10−3mm2/s) and lowest for PRCCs (0.575 ± 0.043 × 10−3mm2/s) (Figs. 2, 3). The D parameter showed also high statistically significant difference in differentiating clear cell type from non-clear cell types including both chromophobe & papillary types, p < 0.001 for both (Table 1). The area under curve for Diffusion coefficient (D) was excellent (AUC = 1.0), and the cutoff point of D value was ≥ 0.835 for distinguishing CCRCCs from non-clear cell types (ChRCCs and PRCCs) with sensitivity of 100% and specificity of 97.2% (Table 2), (Figs. 6, 7, 8).

Fig. 2
figure 2

The mean values for D, D* and f among the three subtypes, CCRCC, PRCC and ChRCCs. D diffusion coefficient, D*pseudo-diffusion, f perfusion fraction, CCRCC clear cell renal cell carcinoma, PRCC papillary renal cell carcinoma, ChRCCs chromophobe renal cell carcinoma

Fig. 3
figure 3

Boxplot shows the difference between clear cell, papillary and chromophobe RCCs measurements according to the D parameter within the studied groups. The D values were highest for CCRCC (1.44 ± 0.19 × 10−3mm2/s) followed by ChRCCs (0.751 + 0.054 × 10−3mm2/s) and lowest for PRCC (0.575 + 0.043 × 10−3mm2/s). D diffusion coefficient, CCRCC clear cell renal cell carcinoma, ChRCCs chromophobe renal cell carcinoma, PRCC papillary renal cell carcinoma

Table 1 Relation between radiological findings as regard D, D* and f and histopathology among studied cases
Table 2 Validity of D, D* and f in differentiating clear cell type (CCRCC) from non-clear cell types (ChRCCs & PRCC)

Regarding the D* parameter, CCRCCs also had the highest D* values (0.035 ± 0.006 mm2/s) followed by PRCCs (0.033 ± 0.002 mm2/s) and lowest for ChRCCs (0.022 ± 0.004 mm2/s) (Figs. 2, 4). Statistically significant difference was detected among CCRCCs & ChRCCs types and between PRCCs & ChRCCs (P < 0.001 for both), but no statistically significant difference was detected between CCRCCs & PRCCs (p = 0.084) (Table 1). AUC for pseudo-diffusion (D*) is good (AUC = 0.745), with the best detected cutoff point for differentiating CCRCCs from non-clear cell types (ChRCCs and PRCCs) that is ≤ 0.0355 yielding sensitivity of 57.5% and specificity 83.3% (Table 2), (Figs. 6, 7, 8).

Fig. 4
figure 4

Boxplot shows the difference between clear cell, papillary and chromophobe RCCs measurements according to the D* parameter within the studied groups. The D* values were highest for CCRCCs (0.035 ± 0.006 mm2/s) followed by PRCCs (0.033 ± 0.002 mm2/s) and lowest for ChRCCs (0.022 ± 0.004 mm2/s). D* diffusion coefficient, CCRCC clear cell renal cell carcinoma, ChRCC chromophobe renal cell carcinoma, PRCC papillary renal cell carcinoma

The f values were highest for CCRCCs (0.449 ± 0.16%) followed by ChRCCs (0.347 ± 0.07%) and lowest for PRCCs (0.286 ± 0.045%) (Figs. 2, 5). Statistically significant difference was detected between CCRCCs & PRCCs (P1 < 0.001) and between CCRCCs & ChRCCs (P2 < 0.008), but no statistically significant difference was detected between ChRCCs & PRCCs (P3 = 0.139) (Table 1). Area under curve for perfusion fraction (f) was excellent (AUC = 0.823), with the best detected cutoff point for differentiating CCRCCs from non-clear cell types (ChRCCs and PRCCs) that is ≤ 0.355 yielding sensitivity of 72.7%, specificity 76.5% (Table 2), (Figs. 6, 7, 8).

Fig. 5
figure 5

Boxplot shows the difference between clear cell, papillary and chromophobe RCCs measurements according to the f parameter within the studied groups. The f values were highest for CCRCCs (0.449 ± 0.16%) followed by ChRCCs (0.347 ± 0.07%) and lowest for PRCCs (0.286 ± 0.045%). f perfusion fraction, CCRCC clear cell renal cell carcinoma, ChRCC chromophobe renal cell carcinoma, PRCC papillary renal cell carcinoma

Fig. 6
figure 6

A 63-year-old male patient presented with left lower polar soft tissue mass confirmed as clear cell RCC by histopathology. A Coronal T2WI showing heterogenous SI of the renal mass. BD Showing D, D* and f maps with measured values as 1.23 × 10–3 mm2/s, 0.028 mm2/s and 0.43%, respectively. E ROC curve of D, D* & F in differentiating clear cell RCC from non-clear cell types (ChRCC & PRCC)

Fig. 7
figure 7

A 52-year-old male patient presented with right lower polar soft tissue mass confirmed as papillary RCC by histopathology. A Coronal T2WI showing heterogenous SI of the renal mass. BD Showing D, D* and f maps with measured values as 0.53 × 10–3 mm2/s, 0.031 mm2/s and 0.22%, respectively. E ROC curve of D, D* & f in differentiating papillary RCC from other types (CCRCC & ChRCC)

Fig. 8
figure 8

A 48-year-old male patient presented with right upper polar soft tissue mass confirmed as chromophobe RCC by histopathology. A Coronal T2WI showing intermediate SI of the renal mass. BD Showing D, D* and f maps with measured values as 0.73 × 10–3 mm2/s, 0.023 mm2/s and 0.29%, respectively. E ROC curve of D, D* & f in differentiating chromophobe cell RCC from other types (CCRCC & PRCC)

Discussion

Renal cell carcinoma is the most fatal form of renal tumors, representing about ninety percent of all renal cancers, and its incidence increases annually by about 2–3% [16]. The most predominant subtype of RCC is clear cell type, representing about 75%. It is also the worst form of RCCs regarding its prognosis with five-year survival rate ranging from 44 to 69% [3, 17].

Multiparametric MRI has recently become the most reliable method for differentiation of renal tumors, yet other advanced MRI techniques are still required to evaluate renal tumor subtypes. ADC is a quantitative method determined from MR-DWI images that is affected by numerous physiological and pathological states of the renal system [18].

IVIM can be done without the need of contrast agents’ injection to offer a distinctive image of the tissue perfusion. The proportion of tumor tissue cellularity and vascularity varies between renal tumor types; therefore, the IVIM parameters including D, D* and f can represent different issues that operate within ADC and can offer accurate and sensitive assessment of renal masses [13].

The random microscopic movement of water molecules in extra- or intracellular spaces as well as in the blood microcirculation that arises in each voxel on MR images is reflected by IVIM [9]. IVIM theory suggested that a number of tissue characteristics, such as the existence of restricting barriers inside the tissue, the fluid consistency in which the spinning molecules are spreading, the speed and fractional volume of perfusing spins all have an impact on perfusion and diffusion [11].

Assessment of renal tumors is beneficial in determining masses that require surgical excision with no further assessment by biopsy from masses that need active surveillance or ablation [19]. Therefore, we conducted this prospective study, with the primary aim that is to assess role of IVIM in renal cell carcinomas characterization and differentiation in correlation with histopathology subtypes.

In our study, CCRCCs showed the highest D values followed by ChRCCs and lowest for PRCCs. The D parameter showed also high significant statistical difference between clear cell type and both chromophobe & papillary types, P < 0.001 for both with the best detected cutoff value for discrimination of clear cell types versus non-clear cell types is ≥ 0.835 with (AUC = 1.0) yielding sensitivity of 100.0% and specificity 97.2%. Tissue cellularity and perfusion have an impact on the D values. It was reported that lower D values have been correlated to greater cellularity in several studies [20]. Also, the lower D values could be caused by the viscosity of the tumor or mechanical restriction of water diffusion by barriers such cell membranes. The cells of clear cell RCC are rich in phospholipids, cholesterol and neutral lipids. Moreover, tumor cells of CCRCCs are separated by interstitial spaces and have hemorrhagic and cystic areas, which allowed water to spread freely [21].

As regard the f parameter, it nearly showed the same results as the D parameter, its values were high within CCRCCs, moderate within ChRCCs and low within PRCC, but we found significant statistical difference among CCRCCs & PRCCs (P < 0.001), as well as CCRCCs & ChRCCs (P < 0.008). But significant statistical difference noticed among PRCCs & ChRCCs (P = 0.139) with best detected cutoff value for discrimination of clear cell types versus non-clear cell types that is ≤ 0.355 (AUC = 0.823), resulting in sensitivity about 72.7% and specificity about 76.5%.

Comparable to our findings, Zhu, Qingqiang et al. 2019 mentioned that the f and D values were high within CCRCCs, moderate within ChRCCs and low within PRCC. The D values of CCRCCs showed significant statistical difference among ChRCCs and PRCCs (P < 0.05) with f and D measurements of 0.41 and 1.10, respectively, as the cutoff value for distinguishing CCRCCs versus both PRCCs and ChRCCs [22].

Our results detected that the CCRCCs had also the greatest D* values, but moderate values were detected among PRCCs and least values detected among ChRCCs. Significant statistical difference was detected among CCRCCs & ChRCCs types as well as among PRCCs & ChRCCs (P < 0.001 for both). However, no significant statistical difference was detected among CCRCCs & PRCCs (p = 0.084) with best detected cutoff value to differentiate CCRCCs from ChRCCs and PRCCs that is ≤ 0.0355 (AUC = 0.745) yielding sensitivity of 57.5% and specificity 83.3%. D* values may be influenced by capillary density and vascular perfusion. The tissue capillary density is probably the reason for rising D* values as clear cell RCCs are hypervascular renal tumors [23].

Our results are on the same level of agreement with Ding, Yuqin, et al.,2016 study; they mentioned that the three subtypes of RCCs had significant statistical difference for D* and D (all p < 0.050) and also mentioned that CCRCCs exhibited the greatest D values. Regarding the f values their results suggested that CCRCCs had greater f values in comparison with non-CCRCCs (p < 0.05) [24]. Contrary to our findings Chandarana, Hersh, et al.,2012, they reported that f parameter had higher accuracy versus D parameter (AUC = 0.74) to diagnose clear cell type, but the utilization and measurements of both f and D parameters together had the greatest accuracy (AUC = 0.78) [25].

Our research is subject to some limitations: First, the number of cases was not large and only limited number of cases enrolled within every subgroup, this might influence the reproducibility and validity of the findings, so larger sample size may be necessary to ensure our results. Second, the cases enrolled in the study were not reflective of majority of people because the research had enrolled only patients who were referred to a specialized center, which may have resulted in a biased sample. Third, there was a possibility of false(-ve) results as we might miss small foci of the tumor. Finally, our study may have lacked continuous surveillance to assess patients’ clinical outcomes. For example, the study may have assessed the diagnostic accuracy of IVIM, but not its ability to predict the prognosis.

In summary, this study clarified that IVIM parameters differ significantly among renal cell carcinoma subtypes. This approach may be used as a non-invasive technique for differentiating between renal cell cancer subtypes. Even so, we cannot replace percutaneous biopsy by these radiological findings as there is major overlapping among different renal tumors.

Conclusions

In conclusion, the current study showed that IVIM quantitative parameters show the potential to favor the RCC diagnosis and characterization. It may be a hopeful method for assessment of the pathological alterations of RCC tissue, such as predict CCRCC versus non-CCRCC subtypes.

The current study has found that D value varies majorly among different subtypes of CCRCC which may reflect differences in tissue microstructure and cellular density between them and can be elucidated with RCC hypercellularity. IVIM, when used with routine MRI of kidney may be valuable in improving the specificity and the sensitivity of detection of RCC particularly combined D, D* & f showed good to excellent non-invasive diagnostic accuracy in differentiating subtypes of RCC potentially reducing the need for invasive procedures such as biopsies.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Abbreviations

RCC:

Renal cell carcinoma

MRI:

Magnetic resonance image

IVIM:

Intravoxel incoherent motion

DWI:

Diffusion-weighted images

CCRCC:

Clear cell renal cell carcinoma

PRCC:

Papillary renal cell carcinoma

ChRCC:

Chromophobe renal cell carcinoma

WHO:

World Health Organization

D:

True diffusion coefficient

D*:

Pseudo-diffusion

F:

Perfusion fraction

ADC:

Apparent diffusion coefficient

US:

Ultrasound

CT:

Computed tomography

FOV:

Field of view

TE:

Echoe time

TR:

Repetition time

ROI:

Region of interest

AUC:

Area under the curve

References

  1. Siegel RL, Miller KD, Jemal A (2018) Cancer statistics. CA Cancer J Clin 68(1):7–30

    Article  PubMed  Google Scholar 

  2. Wang W, Cao K, Jin S, Zhu X, Ding J, Peng W et al (2020) Differentiation of renal cell carcinoma subtypes through MRI-based radiomics analysis. Eur Radiol 30:5738–5747

    Article  PubMed  Google Scholar 

  3. Armstrong AJ, Halabi S, Eisen T, Broderick S, Stadler WM, Jones RJ et al (2016) Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial. Lancet Oncol 17:378–388

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Williamson SR et al (2020) Report from the International Society of Urological Pathology (ISUP) consultation conference on molecular pathology of urogenital cancers: III: molecular pathology of kidney cancer. Am J Surg Pathol 44(7):e47

    Article  PubMed  PubMed Central  Google Scholar 

  5. Serter A, Onur MR, Coban G, Yildiz P, Armagan A, Kocakoc E et al (2021) The role of diffusion-weighted MRI and contrast-enhanced MRI for differentiation between solid renal masses and renal cell carcinoma subtypes. Abdom Radiol 46:1041–1052

    Article  Google Scholar 

  6. Cornelis F, Grenier N (2017) Multiparametric magnetic resonance imaging of solid renal tumors: a practical algorithm. Seminars Ultrasound CT MRI 38(1):47–58

    Article  Google Scholar 

  7. Elsorougy A et al (2021) Quantitative 3-tesla multiparametric MRI in differentiation between renal cell carcinoma subtypes. Egypt J Radiol Nucl Med 52(1):1–11

    Article  Google Scholar 

  8. Rouvière O et al (2020) Imaging protocols for renal multiparametric MRI and MR urography: results of a consensus conference from the French Society of Genitourinary Imaging. Eur Radiol 30:2103–2114

    Article  PubMed  Google Scholar 

  9. Iima M (2021) Perfusion-driven intravoxel incoherent motion (IVIM) MRI in oncology: applications, challenges, and future trends. Magn Reson Med Sci 20(2):125–138

    Article  CAS  PubMed  Google Scholar 

  10. Pan J, Zhang H, Man F, Shen Y, Wang Y, Zhong Y, Ma L et al (2018) Measurement and scan reproducibility of parameters of intravoxel incoherent motion in renal tumor and normal renal parenchyma: a preliminary research at 3.0 T MR. Abdom Radiol 43:17391748

    Article  Google Scholar 

  11. Zhu Q, Zhu W, Ye J, Wu J, Chen W, Hao Z et al (2019) Value of intravoxel incoherent motion for differential diagnosis of renal tumors. Acta Radiol 60:382–387

    Article  PubMed  Google Scholar 

  12. Chandarana H, Rosenkrantz AB, Mussi TC, Kim S, Ahmad AA, Raj SD et al (2012) Histogram analysis of whole-lesion enhancement in differentiating clear cell from papillary subtype of renal cell cancer. Radiology 265:790–798

    Article  PubMed  Google Scholar 

  13. Shubert-Franczak AE et al (2020) Intravoxel incoherent motion magnetic resonance imaging: basic principles and clinical applications. Pol J Radiol 85(1):624–635

    Article  Google Scholar 

  14. Spannuth WA, Sood AK, Coleman RL (2008) Angiogenesis as a strategic target for ovarian cancer therapy. Nat Clin Pract Oncol 5:194–204

    Article  CAS  PubMed  Google Scholar 

  15. Low G, Huang G, Fu W, Moloo Z, Girgis S et al (2016) Review of renal cell carcinoma and its common subtypes in radiology. World J Radiol 8:484–500

    Article  PubMed  PubMed Central  Google Scholar 

  16. Lopes Vendrami C, Parada Villavicencio C, DeJulio TJ, Chatterjee A, Casalino DD, Horowitz JM et al (2017) Differentiation of solid renal tumors with multiparametric MR imaging. Radiographics 37(7):2026–2042

    Article  PubMed  Google Scholar 

  17. De Leon AD, Kapur P, Pedrosa I (2019) Radiomics in kidney Cancer: MR imaging. Magn Reson Imaging Clin 27(1):1–13

    Article  Google Scholar 

  18. Li YT, Cercueil JP, Yuan J et al (2017) Liver intravoxel incoherent motion (IVIM) magnetic resonance imaging: a comprehensive review of published data on normal values and applications for fibrosis and tumor evaluation. Quant Imaging Med Surg 7:59–78

    Article  PubMed  PubMed Central  Google Scholar 

  19. Hsieh JJ et al (2018) Genomic classifications of renal cell carcinoma: A critical step towards the future application of personalized kidney cancer care with pan-omics precision. J Pathol 244(5):525–537

    Article  PubMed  Google Scholar 

  20. Eckerbom P, Hansell P, Bjerner T et al (2013) Intravoxel incoherent motion MR imaging of the kidney: pilot study. Adv Exp Med Biol 765:55–58

    Article  CAS  PubMed  Google Scholar 

  21. Koh MJ, Lim BJ, Choi KH et al (2013) Renal histologic parameters influencing postoperative renal function in renal cell carcinoma patients. Korean J Pathol 47:557–562

    Article  PubMed  PubMed Central  Google Scholar 

  22. Zhu Q et al (2019) Value of intravoxel incoherent motion for differential diagnosis of renal tumors. Acta Radiol 60(3):382–387

    Article  PubMed  Google Scholar 

  23. Wang H, Cheng L, Zhang X (2010) Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T. Radiology 257:135–143

    Article  PubMed  Google Scholar 

  24. Ding Y et al (2016) Comparison of biexponential and monoexponential model of diffusion-weighted imaging for distinguishing between common renal cell carcinoma and fat poor angiomyolipoma. Korean J Radiol 17(6):853

    Article  PubMed  PubMed Central  Google Scholar 

  25. Chandarana H et al (2012) Diffusion-weighted intravoxel incoherent motion imaging of renal tumors with histopathologic correlation. Invest Radiol 47(12):688–696

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We acknowledge all members of the Radiology Department in Urology and Nephrology Center, Mansoura University, Egypt.

Funding

This study had no funding from any resource.

Author information

Authors and Affiliations

Authors

Contributions

AM contributed to the data collection. AM and AE performed data analysis and writing. AE, NF and EH performed supervision. They all approved the final revision of the manuscript.

Corresponding author

Correspondence to Amira R. Mahmoud.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the Research Ethics Committee of the Faculty of Medicine at Mansoura University in Egypt on 06/03/2023; reference number of approval: (MS.23.02.2297).

Consent for publication

All patients included in this research gave written informed consent to publish the data contained within this study.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mahmoud, A.R., Fouda, N., Helmy, E.M. et al. Role of intravoxel incoherent motion diffusion-weighted MRI in differentiation of renal cell carcinoma subtypes. Egypt J Radiol Nucl Med 55, 184 (2024). https://doi.org/10.1186/s43055-024-01352-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s43055-024-01352-6

Keywords